Immunohistochemical Ki67 labeling index has similar proliferation predictive power to various gene signatures in breast cancer

Naoki Niikura, Takayuki Iwamoto, Shinobu Masuda, Nobue Kumaki, Tang Xiaoyan, Masatoshi Shirane, Kazushige Mori, Banri Tsuda, Takuho Okamura, Yuki Saito, Yasuhiro Suzuki, Yutaka Tokuda

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

The objective of this study was to examine the association between the immunohistochemical Ki67 labeling index (IHC Ki67), Ki67 mRNA expression level, and first-generation gene signatures in a cohort of breast cancer patients. We assessed associations between IHC Ki67 and first-generation gene signatures in a panel of 39 tumor samples, using an oligonucleotide microarray. Gene expression analyses included Ki67 alone (MKi67), 21-gene signature, mitosis kinome score signature, and genomic grade index. Correlation coefficients were calculated by Spearman's rank correlation test. In all cases, IHC Ki67, MKi67, and three genetic markers were highly correlated (ρ, 0.71-0.97). Estrogen receptor (ER)-positive cases showed strong correlations between IHC Ki67 and other signatures (ρ, 0.79-0.83). The ER-negative cases showed slightly lower correlations (ρ, 0.58-0.73). In ER-positive cases, the low IHC Ki67 group showed significantly longer relapse-free survival than the high IHC Ki67 group (P = 0.007). This difference was confirmed by multivariate analysis. Our data indicate that IHC Ki67 shows similar predictive power for proliferation in ER-positive cancers as genomic markers. Further study of IHC Ki67 is needed to define prognostic factors and predictive factors for chemotherapy using central laboratory assessment.

Original languageEnglish
Pages (from-to)1508-1512
Number of pages5
JournalCancer Science
Volume103
Issue number8
DOIs
Publication statusPublished - Aug 2012

Fingerprint

Estrogen Receptors
Breast Neoplasms
Genes
Oligonucleotide Array Sequence Analysis
Genetic Markers
Mitosis
Neoplasms
Multivariate Analysis
Gene Expression
Recurrence
Drug Therapy
Messenger RNA
Survival

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Immunohistochemical Ki67 labeling index has similar proliferation predictive power to various gene signatures in breast cancer. / Niikura, Naoki; Iwamoto, Takayuki; Masuda, Shinobu; Kumaki, Nobue; Xiaoyan, Tang; Shirane, Masatoshi; Mori, Kazushige; Tsuda, Banri; Okamura, Takuho; Saito, Yuki; Suzuki, Yasuhiro; Tokuda, Yutaka.

In: Cancer Science, Vol. 103, No. 8, 08.2012, p. 1508-1512.

Research output: Contribution to journalArticle

Niikura, N, Iwamoto, T, Masuda, S, Kumaki, N, Xiaoyan, T, Shirane, M, Mori, K, Tsuda, B, Okamura, T, Saito, Y, Suzuki, Y & Tokuda, Y 2012, 'Immunohistochemical Ki67 labeling index has similar proliferation predictive power to various gene signatures in breast cancer', Cancer Science, vol. 103, no. 8, pp. 1508-1512. https://doi.org/10.1111/j.1349-7006.2012.02319.x
Niikura, Naoki ; Iwamoto, Takayuki ; Masuda, Shinobu ; Kumaki, Nobue ; Xiaoyan, Tang ; Shirane, Masatoshi ; Mori, Kazushige ; Tsuda, Banri ; Okamura, Takuho ; Saito, Yuki ; Suzuki, Yasuhiro ; Tokuda, Yutaka. / Immunohistochemical Ki67 labeling index has similar proliferation predictive power to various gene signatures in breast cancer. In: Cancer Science. 2012 ; Vol. 103, No. 8. pp. 1508-1512.
@article{2a1fbd929706435294abc2ff64b80787,
title = "Immunohistochemical Ki67 labeling index has similar proliferation predictive power to various gene signatures in breast cancer",
abstract = "The objective of this study was to examine the association between the immunohistochemical Ki67 labeling index (IHC Ki67), Ki67 mRNA expression level, and first-generation gene signatures in a cohort of breast cancer patients. We assessed associations between IHC Ki67 and first-generation gene signatures in a panel of 39 tumor samples, using an oligonucleotide microarray. Gene expression analyses included Ki67 alone (MKi67), 21-gene signature, mitosis kinome score signature, and genomic grade index. Correlation coefficients were calculated by Spearman's rank correlation test. In all cases, IHC Ki67, MKi67, and three genetic markers were highly correlated (ρ, 0.71-0.97). Estrogen receptor (ER)-positive cases showed strong correlations between IHC Ki67 and other signatures (ρ, 0.79-0.83). The ER-negative cases showed slightly lower correlations (ρ, 0.58-0.73). In ER-positive cases, the low IHC Ki67 group showed significantly longer relapse-free survival than the high IHC Ki67 group (P = 0.007). This difference was confirmed by multivariate analysis. Our data indicate that IHC Ki67 shows similar predictive power for proliferation in ER-positive cancers as genomic markers. Further study of IHC Ki67 is needed to define prognostic factors and predictive factors for chemotherapy using central laboratory assessment.",
author = "Naoki Niikura and Takayuki Iwamoto and Shinobu Masuda and Nobue Kumaki and Tang Xiaoyan and Masatoshi Shirane and Kazushige Mori and Banri Tsuda and Takuho Okamura and Yuki Saito and Yasuhiro Suzuki and Yutaka Tokuda",
year = "2012",
month = "8",
doi = "10.1111/j.1349-7006.2012.02319.x",
language = "English",
volume = "103",
pages = "1508--1512",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Immunohistochemical Ki67 labeling index has similar proliferation predictive power to various gene signatures in breast cancer

AU - Niikura, Naoki

AU - Iwamoto, Takayuki

AU - Masuda, Shinobu

AU - Kumaki, Nobue

AU - Xiaoyan, Tang

AU - Shirane, Masatoshi

AU - Mori, Kazushige

AU - Tsuda, Banri

AU - Okamura, Takuho

AU - Saito, Yuki

AU - Suzuki, Yasuhiro

AU - Tokuda, Yutaka

PY - 2012/8

Y1 - 2012/8

N2 - The objective of this study was to examine the association between the immunohistochemical Ki67 labeling index (IHC Ki67), Ki67 mRNA expression level, and first-generation gene signatures in a cohort of breast cancer patients. We assessed associations between IHC Ki67 and first-generation gene signatures in a panel of 39 tumor samples, using an oligonucleotide microarray. Gene expression analyses included Ki67 alone (MKi67), 21-gene signature, mitosis kinome score signature, and genomic grade index. Correlation coefficients were calculated by Spearman's rank correlation test. In all cases, IHC Ki67, MKi67, and three genetic markers were highly correlated (ρ, 0.71-0.97). Estrogen receptor (ER)-positive cases showed strong correlations between IHC Ki67 and other signatures (ρ, 0.79-0.83). The ER-negative cases showed slightly lower correlations (ρ, 0.58-0.73). In ER-positive cases, the low IHC Ki67 group showed significantly longer relapse-free survival than the high IHC Ki67 group (P = 0.007). This difference was confirmed by multivariate analysis. Our data indicate that IHC Ki67 shows similar predictive power for proliferation in ER-positive cancers as genomic markers. Further study of IHC Ki67 is needed to define prognostic factors and predictive factors for chemotherapy using central laboratory assessment.

AB - The objective of this study was to examine the association between the immunohistochemical Ki67 labeling index (IHC Ki67), Ki67 mRNA expression level, and first-generation gene signatures in a cohort of breast cancer patients. We assessed associations between IHC Ki67 and first-generation gene signatures in a panel of 39 tumor samples, using an oligonucleotide microarray. Gene expression analyses included Ki67 alone (MKi67), 21-gene signature, mitosis kinome score signature, and genomic grade index. Correlation coefficients were calculated by Spearman's rank correlation test. In all cases, IHC Ki67, MKi67, and three genetic markers were highly correlated (ρ, 0.71-0.97). Estrogen receptor (ER)-positive cases showed strong correlations between IHC Ki67 and other signatures (ρ, 0.79-0.83). The ER-negative cases showed slightly lower correlations (ρ, 0.58-0.73). In ER-positive cases, the low IHC Ki67 group showed significantly longer relapse-free survival than the high IHC Ki67 group (P = 0.007). This difference was confirmed by multivariate analysis. Our data indicate that IHC Ki67 shows similar predictive power for proliferation in ER-positive cancers as genomic markers. Further study of IHC Ki67 is needed to define prognostic factors and predictive factors for chemotherapy using central laboratory assessment.

UR - http://www.scopus.com/inward/record.url?scp=84864310664&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864310664&partnerID=8YFLogxK

U2 - 10.1111/j.1349-7006.2012.02319.x

DO - 10.1111/j.1349-7006.2012.02319.x

M3 - Article

C2 - 22537114

AN - SCOPUS:84864310664

VL - 103

SP - 1508

EP - 1512

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 8

ER -